Amedeo Smart

Free Medical Literature Service

 

Amedeo

Breast Cancer
  Free Subscription

Articles published in
J Biol Chem
    September 2026
  1. YANG Y, Wang B
    Monitoring Py8119 breast cancer cell proliferation in direct cocultures with osteoblasts and osteoclasts.
    J Biol Chem. 2026 Sep 23:113597. doi: 10.1016/j.jbc.2026.113597.
    >> Share

  2. SYEDA AK, Almasi S, Benson CJ, Kennedy BE, et al
    TRPML1 loss disrupts lysosome-mitochondria homeostasis and sensitizes MDA-MB-231 triple-negative breast cancer cells to chemotherapy.
    J Biol Chem. 2026 Sep 22:113596. doi: 10.1016/j.jbc.2026.113596.
    >> Share

  3. DAW JN, Moly PK, Chung S, Young S, et al
    Nitric oxide dependent metabolic and genetic dysregulation in metastatic triple-negative breast cancer.
    J Biol Chem. 2026 Sep 8:113526. doi: 10.1016/j.jbc.2026.113526.
    >> Share

  4. QIAN T, Liu X, Bai F, He Q, et al
    USP11 deubiquitinates GATA3 to suppress the growth and metastasis of luminal-type breast cancers.
    J Biol Chem. 2026;302:113371.
    >> Share

    August 2026
  5. SWAROOP B SS, Gopinath P, Kanumuri R, Seetharaman A, et al
    PAK1 mediated phosphorylation of ARGLU1 promotes tumorigenic potential of Breast cancer.
    J Biol Chem. 2026 Aug 25:113491. doi: 10.1016/j.jbc.2026.113491.
    >> Share

  6. LERO MW, Morgan JS, Card MA, Zhu LJ, et al
    Insulin receptor substrate 2 (IRS2) confers resistance to PI3K pathway inhibition in PIK3CA mutant breast cancer.
    J Biol Chem. 2026 Aug 10:113426. doi: 10.1016/j.jbc.2026.113426.
    >> Share

    July 2026
  7. PIMENTEL JM, Bosompra O, Trejo J
    The deubiquitinase CYLD inhibits thrombin-induced p38 MAPK-p65 NF-kappaB signaling and inflammatory cytokine production to suppress triple-negative breast cancer progression.
    J Biol Chem. 2026 Jul 16:113341. doi: 10.1016/j.jbc.2026.113341.
    >> Share

    June 2026
  8. SONG H, Lu J, Zhang Y, Lv Z, et al
    FTO Promotes Cancer Progression by Regulating VGLL4 m6A Levels to Activate STAT3 Signaling in Triple-Negative Breast Cancer.
    J Biol Chem. 2026 Jun 9:113242. doi: 10.1016/j.jbc.2026.113242.
    >> Share

    May 2026
  9. SUZUKI Y, Kitayama N, Kudo R, Silwal K, et al
    The cellular stress sensor HSPB1 regulates the membrane localization of amino acid transporter SLC7A5 in breast cancer.
    J Biol Chem. 2026 May 27:113197. doi: 10.1016/j.jbc.2026.113197.
    >> Share

  10. LI X, Liu L, Luo L, Deng M, et al
    Low-dose EGFR inhibition unlocks ferroptosis susceptibility to sensitize chemotherapy in EGFR- high triple-negative breast cancer.
    J Biol Chem. 2026 May 25:113185. doi: 10.1016/j.jbc.2026.113185.
    >> Share

  11. HUMPHRIES BA, Wang Z, Yang C
    Methylation Marks Breast Cancer Metastasis: The Roles of m(6)A-Modified miRNAs and lncRNAs.
    J Biol Chem. 2026 May 6:113127. doi: 10.1016/j.jbc.2026.113127.
    >> Share

    April 2026
  12. PU P, Jin Y, Zhang S, Xu Y, et al
    A Tri-specific EGFR/cMet/VEGF Antibody Demonstrates Potent Multi-Mechanistic Activity in Preclinical Triple-Negative Breast Cancer Models.
    J Biol Chem. 2026 Apr 30:113100. doi: 10.1016/j.jbc.2026.113100.
    >> Share

    February 2026
  13. ROSENTHAL KJ, Felix-Sanchez P, Forbush K, Rhoads N, et al
    AKAP2 is required for assembly of cytoskeletal signaling complexes that promote growth and metastasis of triple-negative breast cancer.
    J Biol Chem. 2026 Feb 26:111329. doi: 10.1016/j.jbc.2026.111329.
    >> Share

  14. DOLUI B, Majumdar B, Bandyopadhyay A, Desai KV, et al
    TIM-3 inhibition enhances breast tumor progression and metastasis: A paradoxical immune checkpoint response.
    J Biol Chem. 2026;302:111096.
    >> Share

    December 2025
  15. LARIZ FJ, Hernandez S, Bautista-Tovar DC, Houston KD, et al
    IGFBP-6 Regulates Breast Cancer Cell Cycle Progression by Promoting Exit Out of G1.
    J Biol Chem. 2025 Dec 17:111069. doi: 10.1016/j.jbc.2025.111069.
    >> Share

  16. MAIER S, Schroth W, Mier F, Matt L, et al
    Tamoxifen metabolites acting via BK(Ca) orchestrate the dynamics of K(+) and Ca(2+) in breast cancer cells.
    J Biol Chem. 2025 Dec 6:111015. doi: 10.1016/j.jbc.2025.111015.
    >> Share

  17. NAGASATO-ICHIKAWA A, Murakami K, Aoki K, Okada M, et al
    The receptor tyrosine kinase ErbB2/HER2 governs CDK4 inhibitor sensitivity, timing, and irreversibility of the G1/S transition.
    J Biol Chem. 2025;301:110865.
    >> Share

    November 2025
  18. SARKAR S, Chatterjee A, Paul S, Bisoi A, et al
    G-Quadruplex-specific action of chloroquine-based immunomodulator drugs to inhibit the cancer progression.
    J Biol Chem. 2025;301:110753.
    >> Share

    October 2025
  19. SANTJER S, Xu Y, Riethdorf S, Schon G, et al
    The activity of the EMT suppressor GRHL2 is regulated by SUMOylation.
    J Biol Chem. 2025;301:110662.
    >> Share

    September 2025
  20. NANDI S, Mondal A, Sarkar I, Akram Ddoza Hazari MW, et al
    The Hypoxia-Induced Chromatin Reader ZMYND8 Drives HIF-Dependent Metabolic Rewiring in Breast Cancer.
    J Biol Chem. 2025 Sep 3:110680. doi: 10.1016/j.jbc.2025.110680.
    >> Share

  21. LI X, Chung YM, Patel M, Sharifi N, et al
    Correction: of HSD3B1 upregulation via LRH1 sustains estrogen receptor signaling and promotes endocrine resistance in breast cancer.
    J Biol Chem. 2025;301:110553.
    >> Share

  22. ZHAO M, Yuan D, Wei M, Zhang J, et al
    FOXO1- mediated argininosuccinate lyase transcription inhibits ammonia metabolism and breast cancer cell metastasis.
    J Biol Chem. 2025 Sep 2:110677. doi: 10.1016/j.jbc.2025.110677.
    >> Share

  23. YU H, Zhou Q, Chen Y, Zhong C, et al
    Neddylation inhibitor MLN4924 enhances H3K18 lactylation via binding to LDH and downregulates ITGB4 to block metastasis.
    J Biol Chem. 2025;301:110575.
    >> Share

    August 2025
  24. YOSHIOKA Y, Nosaka C, Ohishi T, Nakajima M, et al
    Loss of Angulin-1/LSR promotes vasculogenic mimicry and epithelial-mesenchymal transition in breast cancer.
    J Biol Chem. 2025 Aug 27:110635. doi: 10.1016/j.jbc.2025.110635.
    >> Share

  25. SONG H, Peng J, Niu Z, Liu X, et al
    A non-coding RNA circGNAI2 suppresses triple-negative breast cancer progression by sponging miR-454-3p to inhibit the VGLL4-STAT3 signaling.
    J Biol Chem. 2025 Aug 8:110577. doi: 10.1016/j.jbc.2025.110577.
    >> Share

  26. EL-SAWY L, Rubin JR, Broses L, Patsalis C, et al
    The molecular mechanism of ambrosin induced cytotoxicity of human breast cancer and bladder cancer cells.
    J Biol Chem. 2025 Aug 1:110531. doi: 10.1016/j.jbc.2025.110531.
    >> Share

    July 2025
  27. SCHUMACHER TJ, Gardner ZS, Rumbley J, Ronayne CT, et al
    Development of novel mitochondrial pyruvate carrier inhibitors for breast cancer treatment.
    J Biol Chem. 2025 Jul 16:110486. doi: 10.1016/j.jbc.2025.110486.
    >> Share

  28. PANDEY A, Jithin B, Mutnuru SA, Samaiya A, et al
    Identification of SRSF9 through pooled shRNA screening links BNIP3 splicing to autophagy and metabolic reprogramming in breast cancer.
    J Biol Chem. 2025 Jul 15:110482. doi: 10.1016/j.jbc.2025.110482.
    >> Share

  29. WOYCIEHOWSKY M, Larson P, Stephan AR, Dandridge SL, et al
    Systematic characterization of zinc in a series of breast cancer cell lines reveals significant changes in zinc homeostasis.
    J Biol Chem. 2025 Jul 2:110442. doi: 10.1016/j.jbc.2025.110442.
    >> Share

  30. KHARAT SS, Mishra AP, Sengodan SK, Dierman D, et al
    5hmC enhances PARP trapping and restores PARP inhibitor sensitivity in chemoresistant BRCA1/2-deficient cells.
    J Biol Chem. 2025;301:110393.
    >> Share

  31. SHI S, Li X, Alderman C, Wick L, et al
    Cryo-EM structures reveal the PP2A-B55alpha and Eya3 interaction that can be disrupted by a peptide inhibitor.
    J Biol Chem. 2025;301:110287.
    >> Share

  32. HAN AL, Vinod Paul K, Rao S, Brechbuhl HM, et al
    Estradiol (E2) concentration shapes the chromatin binding landscape of estrogen receptor alpha.
    J Biol Chem. 2025;301:108499.
    >> Share

    June 2025
  33. TANIHARA T, Yoshida Y, Ogino T, Terada Y, et al
    Microcurrent stimulation induces cell death in p53-mutant and 5-FU-resistant breast cancer.
    J Biol Chem. 2025 Jun 24:110414. doi: 10.1016/j.jbc.2025.110414.
    >> Share

  34. LI X, Chung YM, Patel M, Sharifi N, et al
    HSD3B1 Upregulation via LRH1 Sustains Estrogen Receptor Signaling and Promotes Endocrine Resistance in Breast Cancer.
    J Biol Chem. 2025 Jun 20:110405. doi: 10.1016/j.jbc.2025.110405.
    >> Share

  35. SHOARI A, Coban MA, Hockla A, Rezhdo A, et al
    Directed evolution of metalloproteinase inhibitor TIMP-1 for selective inhibition of MMP-9 exploits catalytic and fibronectin domain interactions.
    J Biol Chem. 2025;301:110258.
    >> Share

    May 2025
  36. QIU Y, Luan G, Liu Y, He Y, et al
    The transcriptional regulator Sin3a activates CD44 and promotes collective luminal breast cancer cell migration.
    J Biol Chem. 2025 May 21:110264. doi: 10.1016/j.jbc.2025.110264.
    >> Share

  37. HANG Q, Li W, Guo J, Zuo S, et al
    Inhibitory effects of beta-galactoside alpha2,6-sialyltransferase 1 on the Hippo pathway in breast cancer cells.
    J Biol Chem. 2025 May 21:110266. doi: 10.1016/j.jbc.2025.110266.
    >> Share

  38. MAJMUDAR PR, Keri RA
    The neural stem cell gene PAFAH1B1 controls cell cycle progression, DNA integrity, and paclitaxel sensitivity of triple-negative breast cancer cells.
    J Biol Chem. 2025 May 14:110235. doi: 10.1016/j.jbc.2025.110235.
    >> Share

  39. ZHANG X, Zhuang M, Zhang H, Zhu Y, et al
    Melatonin-mediated cGAS-STING signal in senescent macrophages promote TNBC chemotherapy resistance and drive the SASP.
    J Biol Chem. 2025;301:108438.
    >> Share

    April 2025
  40. LINSTRA R, Stappenbelt C, Bakker FJ, Everts M, et al
    MYC controls STING levels to downregulate inflammatory signaling in breast cancer cells upon DNA damage.
    J Biol Chem. 2025 Apr 29:108560. doi: 10.1016/j.jbc.2025.108560.
    >> Share

  41. -M FAN TW, Yan J, Goncalves CFL, Islam JMM, et al
    Patient-derived organotypic tissue cultures as a platform to evaluate metabolic reprogramming in breast cancer patients.
    J Biol Chem. 2025 Apr 8:108495. doi: 10.1016/j.jbc.2025.108495.
    >> Share

  42. FAN TC, Yeo HL, Hung TH, Chang NC, et al
    ST3GAL1 regulates cancer cell migration through crosstalk between EGFR and neuropilin-1 signaling.
    J Biol Chem. 2025;301:108368.
    >> Share

    March 2025
  43. HU Y, Bian J, Chen W, Shi J, et al
    Androgen receptor-induced lncRNA SOX2-OT promotes triple-negative breast cancer tumorigenesis via targeting miR-320a-5p/CCR5 axis.
    J Biol Chem. 2025 Mar 19:108428. doi: 10.1016/j.jbc.2025.108428.
    >> Share

  44. SENDANAYAKE LR, Pokhrel R, Holub JM
    Surveying helix 12 dynamics within constitutively active estrogen receptors using bipartite tetracysteine display.
    J Biol Chem. 2025;301:108231.
    >> Share

    February 2025
  45. SONG X, Liu S, Zeng Y, Cai Y, et al
    BANCR-Containing Extracellular Vesicles Enhance Breast Cancer Resistance.
    J Biol Chem. 2025 Feb 11:108304. doi: 10.1016/j.jbc.2025.108304.
    >> Share

  46. BOBBITT JR, Cuellar-Vite L, Weber-Bonk KL, Yancey MR, et al
    Targeting the mitotic kinase NEK2 enhances CDK4/6 inhibitor efficacy by potentiating genome instability.
    J Biol Chem. 2025;301:108196.
    >> Share

    January 2025
  47. BAGCHI A, Bhattacharya A, Bera A, Basak D, et al
    PDE4 inhibitor rolipram represses hedgehog signaling via ubiquitin-mediated proteolysis of GLI transcription factors to regress breast cancer.
    J Biol Chem. 2025 Jan 27:108239. doi: 10.1016/j.jbc.2025.108239.
    >> Share

  48. PAUL S, Chatterjee A, Das K, Ray A, et al
    Thrombin confers chemotherapeutic resistance by promoting transcriptional induction and post-translational stabilization of pro-survival MCL1 in TNBC.
    J Biol Chem. 2025;301:108025.
    >> Share

  49. MCDERMOTT N, O'Shea S, Rieger L, Cox OT, et al
    beta(1)-integrin controls IGF-1R internalization and intracellular signaling.
    J Biol Chem. 2025;301:108021.
    >> Share

    December 2024
  50. YU S, Si Y, Xu M, Wang Y, et al
    Downregulation of the splicing regulator NSRP1 confers resistance to CDK4/6 inhibitors via activation of interferon signaling in breast cancer.
    J Biol Chem. 2024 Dec 10:108070. doi: 10.1016/j.jbc.2024.108070.
    >> Share

  51. LETSON J, Ren G, Zheng X, Sweef O, et al
    Reduced S-nitrosylation of TGFbeta1 elevates its binding affinity toward the receptor and promotes fibrogenic signaling in the breast.
    J Biol Chem. 2024;300:108011.
    >> Share

  52. PAN KW, Chen HC
    Perinuclear assembly of vimentin intermediate filaments induces cancer cell nuclear dysmorphia.
    J Biol Chem. 2024;300:107981.
    >> Share

    November 2024
  53. MASSEY S, Kongchan N, Gao Y, Chaudhury A, et al
    PKC-mediated phosphorylation governs the stability and function of CELF1 as a driver of EMT in breast epithelial cells.
    J Biol Chem. 2024;300:107826.
    >> Share

    October 2024
  54. OROBATOR ON, Mertens RT, Obisesan OA, Awuah SG, et al
    Energy and endoplasmic reticulum stress induction by gold(III) dithiocarbamate and 2-deoxyglucose synergistically trigger cell death in breast cancer.
    J Biol Chem. 2024 Oct 29:107949. doi: 10.1016/j.jbc.2024.107949.
    >> Share

  55. SAUNDERS H, Holloran S, Trinca G, Artigues A, et al
    Site specific O-GlcNAcylation of progesterone receptor (PR) supports PR attenuation of interferon stimulated genes (ISGs) and tumor growth in breast cancer.
    J Biol Chem. 2024 Oct 10:107886. doi: 10.1016/j.jbc.2024.107886.
    >> Share

  56. ROTENBERG N, Feldman M, Shirian J, Hockla A, et al
    Engineered TIMP2 with narrow MMP-9 specificity is an effective inhibitor of invasion and proliferation of triple negative breast cancer cells.
    J Biol Chem. 2024 Oct 9:107867. doi: 10.1016/j.jbc.2024.107867.
    >> Share

  57. THI K, Del Toro K, Licon-Munoz Y, Sayaman RW, et al
    Comprehensive identification, isolation, and culture of human breast cell types.
    J Biol Chem. 2024;300:107637.
    >> Share

    September 2024
  58. BERNA-ERRO A, Lopez JJ, Jardin I, Sanchez-Collado J, et al
    Differential functional role of Orai1 variants in constitutive Ca(2+) entry and calcification in luminal breast cancer cells.
    J Biol Chem. 2024 Sep 18:107786. doi: 10.1016/j.jbc.2024.107786.
    >> Share

  59. ZHANG J, Chen Y, Gong X, Yang Y, et al
    GATA factor TRPS1, a new DNA repair protein, cooperates with reversible PARylation to promote chemoresistance in breast cancer patients.
    J Biol Chem. 2024 Sep 12:107780. doi: 10.1016/j.jbc.2024.107780.
    >> Share

  60. CHEN X, Li D, Su Q, Ling X, et al
    SENP3 mediates the deSUMOylation and degradation of YAP1 to regulate the progression of triple-negative breast cancer.
    J Biol Chem. 2024 Sep 11:107764. doi: 10.1016/j.jbc.2024.107764.
    >> Share

  61. QIAN T, Bai F, Zhang S, Xu Y, et al
    USP11 deubiquitinates E-cadherin and maintains luminal fate of mammary tumor cells to suppress breast cancer.
    J Biol Chem. 2024 Sep 11:107768. doi: 10.1016/j.jbc.2024.107768.
    >> Share

    August 2024
  62. TANG K, Yin T, Deng B, Wang M, et al
    USP7 deubiquitinates epigenetic reader ZMYND8 to promote breast cancer cell migration and invasion.
    J Biol Chem. 2024 Aug 9:107672. doi: 10.1016/j.jbc.2024.107672.
    >> Share

    July 2024
  63. PERRON T, Boissan M, Bieche I, Courtois L, et al
    CYYR1 promotes the degradation of the E3 ubiquitin ligase WWP1 and is associated with favorable prognosis in breast cancer.
    J Biol Chem. 2024 Jul 24:107601. doi: 10.1016/j.jbc.2024.107601.
    >> Share

    June 2024
  64. GUO Q, Zhao J, Li Y, Zhang C, et al
    CK2-HTATSF1-TOPBP1 signaling axis modulates tumor chemotherapy response.
    J Biol Chem. 2024;300:107377.
    >> Share

    May 2024
  65. PANDEY A, Kakani P, Shukla S
    CTCF and BORIS-mediated Autophagy regulation via Alternative splicing of BNIP3L in Breast Cancer.
    J Biol Chem. 2024 May 27:107416. doi: 10.1016/j.jbc.2024.107416.
    >> Share

  66. DUAN L, Tadi MJ, O'Hara KM, Maki CG, et al
    Novel markers of MCL1 inhibitor sensitivity in triple negative breast cancer cells.
    J Biol Chem. 2024 May 16:107375. doi: 10.1016/j.jbc.2024.107375.
    >> Share

    April 2024
  67. YANG P, Li Y, Hou J, Wu D, et al
    Blockade of a novel MAP4K4-LATS2-SASH1-YAP1 cascade inhibits tumorigenesis and metastasis in luminal breast cancer.
    J Biol Chem. 2024 Apr 22:107309. doi: 10.1016/j.jbc.2024.107309.
    >> Share

  68. GOEL HL, Karner ER, Kumar A, Mukhopadhyay D, et al
    YAP/TAZ-mediated regulation of laminin 332 is enabled by beta4 integrin repression of ZEB1 to promote ferroptosis resistance.
    J Biol Chem. 2024;300:107202.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016